Ozempic Delivers Major Weight Loss in Adults over 65, Study Finds
The drug also reduced waist size and C-reactive protein, with no overall increase in serious adverse events, researchers said.
4 Articles
4 Articles
Ozempic delivers major weight loss in adults over 65, study finds
A major new analysis suggests semaglutide (Ozempic, Wegovy) works remarkably well in adults over 65, helping many lose substantial amounts of weight while improving heart and metabolic health. Participants taking the drug lost over 15% of their body weight on average — far more than those receiving placebo treatment. Many also moved out of obesity categories entirely and reached healthier weight levels.
A study has found that semaglutide, an ingredient widely used to treat obesity and diabetes, improved physical, metabolic, and cognitive functions in aged mice and even extended their lifespan. Semaglutide is the active ingredient in the obesity drug Wigobi and the diabetes drug Ozempic. Researchers at the University of California administered either semaglutide or saline solution to 20-month-old female mice and observed their health status and …
Semaglutide did more than cut weight in this analysis of 6,239 adults
A systematic review and meta-analysis of nine randomized controlled trials involving 6,239 adults with overweight or obesity without diabetes found that subcutaneous semaglutide produced substantially greater reductions in body weight, waist circumference, and C-reactive protein than placebo. The higher dose of 7.2 mg semaglutide showed potential for greater weight loss, although the evidence is largely based on a single trial and requires confi…
To the list of already known beneficial health effects of semaglutide drugs, such as Ozempic or Wegoby, associated with weight loss and improved glucose control, now researchers at the University of California at Berkeley (United States) have added another: they could contribute to increasing longevity and, above all, quality of life. In a study with aged female mice that received semaglutide for three months, the researchers observed that the a…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
